Literature DB >> 25620276

Diagnosis and management of type II myocardial infarction: increased demand for a limited supply of evidence.

Nathaniel R Smilowitz1, Becky Naoulou, Steven P Sedlis.   

Abstract

Type 2 myocardial infarction (type 2 MI) is defined as myocardial necrosis that results from an imbalance of myocardial oxygen supply and demand. Although type 2 MI is highly prevalent and strongly associated with mortality, the pathophysiology remains poorly understood. Discrepancies in definitions, frequency of screening, diagnostic approaches, and methods of adjudication lead to confusion and misclassification. To date, there is no consensus on the diagnostic criteria for type 2 MI. No guidelines exist for the optimal management of this condition, and further investigation is urgently needed. This review explores the existing evidence on the pathophysiology, diagnosis, prognosis, and management of type 2 MI.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25620276     DOI： 10.1007/s11883-014-0478-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  45 in total

1.  Prognostic significance of cardiac troponin I levels in hospitalized patients presenting with supraventricular tachycardia.

Authors:  Grant V Chow; Glenn A Hirsch; David D Spragg; Jennifer X Cai; Alan Cheng; Roy C Ziegelstein; Joseph E Marine
Journal:  Medicine (Baltimore)       Date:  2010-05       Impact factor: 1.889

2.  Angiographic correlates in type 1 and 2 MI by the universal definition.

Authors:  John A Ambrose; Andreia Loures-Vale; Usman Javed; Cyrus F Buhari; Waqas Aftab
Journal:  JACC Cardiovasc Imaging       Date:  2012-04

Review 3.  Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

Authors:  Robb D Kociol; Peter S Pang; Mihai Gheorghiade; Gregg C Fonarow; Christopher M O'Connor; G Michael Felker
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

4.  Elevated cardiac troponin T levels in critically ill patients with sepsis.

Authors:  Vlad C Vasile; High-Seng Chai; Doaa Abdeldayem; Bekele Afessa; Allan S Jaffe
Journal:  Am J Med       Date:  2013-09-28       Impact factor: 4.965

5.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White; Kristian Thygesen; Joseph S Alpert; Harvey D White; Allan S Jaffe; Hugo A Katus; Fred S Apple; Bertil Lindahl; David A Morrow; Bernard R Chaitman; Peter M Clemmensen; Per Johanson; Hanoch Hod; Richard Underwood; Jeroen J Bax; Jeroen J Bonow; Fausto Pinto; Raymond J Gibbons; Keith A Fox; Dan Atar; L Kristin Newby; Marcello Galvani; Christian W Hamm; Barry F Uretsky; Ph Gabriel Steg; William Wijns; Jean-Pierre Bassand; Phillippe Menasche; Jan Ravkilde; E Magnus Ohman; Elliott M Antman; Lars C Wallentin; Paul W Armstrong; Maarten L Simoons; James L Januzzi; Markku S Nieminen; Mihai Gheorghiade; Gerasimos Filippatos; Russell V Luepker; Stephen P Fortmann; Wayne D Rosamond; Dan Levy; David Wood; Sidney C Smith; Dayi Hu; Jose-Luis Lopez-Sendon; Rose Marie Robertson; Douglas Weaver; Michal Tendera; Alfred A Bove; Alexander N Parkhomenko; Elena J Vasilieva; Shanti Mendis; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Joao Morais; Carlos Aguiar; Wael Almahmeed; David O Arnar; Fabio Barili; Kenneth D Bloch; Ann F Bolger; Hans Erik Botker; Biykem Bozkurt; Raffaele Bugiardini; Christopher Cannon; James de Lemos; Franz R Eberli; Edgardo Escobar; Mark Hlatky; Stefan James; Karl B Kern; David J Moliterno; Christian Mueller; Aleksandar N Neskovic; Burkert Mathias Pieske; Steven P Schulman; Robert F Storey; Kathryn A Taubert; Pascal Vranckx; Daniel R Wagner
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

6.  Cardiac troponin T in patients with clinically suspected myocarditis.

Authors:  B Lauer; C Niederau; U Kühl; M Schannwell; M Pauschinger; B E Strauer; H P Schultheiss
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

7.  Myocardial injury in critically ill patients: relation to increased cardiac troponin I and hospital mortality.

Authors:  Jean-Pierre Quenot; Gwénaël Le Teuff; Catherine Quantin; Jean-Marc Doise; Michal Abrahamowicz; David Masson; Bernard Blettery
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Thrombotic and bleeding complications after orthopedic surgery.

Authors:  Brandon S Oberweis; Swetha Nukala; Andrew Rosenberg; Yu Guo; Steven Stuchin; Martha J Radford; Jeffrey S Berger
Journal:  Am Heart J       Date:  2013-01-08       Impact factor: 4.749

9.  Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients.

Authors:  Luciano Babuin; Vlad C Vasile; Jose A Rio Perez; Jorge R Alegria; High-Seng Chai; Bekele Afessa; Allan S Jaffe
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

10.  Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock.

Authors:  Nirav J Mehta; Ijaz A Khan; Vipin Gupta; Ketan Jani; Ramesh M Gowda; Peter R Smith
Journal:  Int J Cardiol       Date:  2004-05       Impact factor: 4.164
View more
  6 in total

1.  Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis.

Authors:  Nathaniel R Smilowitz; Matthew C Weiss; Rina Mauricio; Asha M Mahajan; Kaitlyn E Dugan; Arvind Devanabanda; Claudia Pulgarin; Eugenia Gianos; Binita Shah; Steven P Sedlis; Martha Radford; Harmony R Reynolds
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

2.  Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction.

Authors:  Nathaniel R Smilowitz; Pritha Subramanyam; Eugenia Gianos; Harmony R Reynolds; Binita Shah; Steven P Sedlis
Journal:  Coron Artery Dis       Date:  2018-01       Impact factor: 1.439

3.  Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States.

Authors:  Nathaniel R Smilowitz; Navdeep Gupta; Yu Guo; Judy Zhong; Catherine R Weinberg; Harmony R Reynolds; Sripal Bangalore
Journal:  Mayo Clin Proc       Date:  2018-07-18       Impact factor: 7.616

4.  Mortality in sepsis: Comparison of outcomes between patients with demand ischemia, acute myocardial infarction, and neither demand ischemia nor acute myocardial infarction.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Brijesh Patel; Byomesh Tripathi; Manyoo Agarwal; Lohit Garg; Sahil Agrawal; Ulrich P Jorde; Matthew W Martinez
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

Review 5.  Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin.

Authors:  Rifly Rafiudeen; Peter Barlis; Harvey D White; William van Gaal
Journal:  Eur Cardiol       Date:  2022-02-17

6.  Microvascular Disease and Perioperative Outcomes of Non-Cardiac Surgery.

Authors:  Nathaniel R Smilowitz; Gabriel Redel-Traub; Jeffery S Berger
Journal:  Am J Cardiol       Date:  2020-10-13       Impact factor: 2.778
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.